Regeneron Pharmaceuticals Inc. said Friday that the U.S. Food and Drug Administration has approved its treatment for CHAPLE disease, a rare and...
Regeneron Pharmaceuticals Inc.
said Friday that the U.S. Food and Drug Administration has approved its treatment for CHAPLE disease, a rare and life-threatening hereditary immune disease. The treatment, Veopoz, is the first to be approved for the condition, which can cause the body to attack normal cells and damage blood and lymph vessels in the upper digestive tract. The monoclonal antibody is approved for adults and children one year of age and older with CHAPLE disease, Regeneron said in a release.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
These are the fastest growing companies in Greater Cleveland, according to the Inc. 5000Cleveland Kitchen, Fund That Flip and The Connect Group are the fastest growing companies in Greater Cleveland.
Consulte Mais informação »
Craft spirits distributor tops Dallas-Fort Worth’s entrants on Inc. 5000 for 2023Topping the Inc. 5000 list for North Texas-based companies is Coppell’s Green Light Distribution, which boasts that it wants to “even the playing field” for...
Consulte Mais informação »
Ceridian HCM Holding Inc Stock Price Today | NYSE CDAY Live TickerView today's Ceridian HCM Holding Inc stock price and latest CDAY news and analysis. Create real-time notifications to follow any changes in the live stock price.
Consulte Mais informação »
Avengers Inc. Trailer Reinvents Most Underrated Avenger as a Noir DetectiveThe Avengers go noir.
Consulte Mais informação »
Ohio City Inc.'s Tom McNair to Head City's Department of Economic DevelopmentMcNair, who spent 15 years growing Ohio City, will now help guide City Hall's strategy citywide
Consulte Mais informação »